Yu-Hsuan Li

发表

5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes.

Chia-Ron Yang, T. Yeh, J. Liou, 2018, Journal of medicinal chemistry.

Effect of C7-substitution of 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines on the selectivity towards a subclass of histone deacetylases.

C. Teng, S. Pan, J. Liou, 2014, Organic & biomolecular chemistry.

1‐Arylsulfonyl‐5‐(N‐hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors

Chia-Ron Yang, C. Teng, T. Yeh, 2013, Chembiochem : a European journal of chemical biology.

2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition.

T. Yeh, J. Liou, Jang-Yang Chang, 2016, Organic & biomolecular chemistry.

Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma

Chia-Ron Yang, C. Teng, J. Liou, 2015, Oncotarget.

2-(Phenylsulfonyl)quinoline N-hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase.

Chia-Ron Yang, Samir Mehndiratta, Han-Li Huang, 2016, European journal of medicinal chemistry.

A novel class I HDAC inhibitor, MPT0G030, induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKCδ and E-cadherin

C. Teng, S. Pan, J. Liou, 2014, Oncotarget.

3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity.

Chia-Ron Yang, Yi-Wen Wu, J. Liou, 2017, European journal of medicinal chemistry.

Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells.

S. Pan, J. Liou, Wei-Cheng Wu, 2020, European journal of medicinal chemistry.

(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo.

Chia-Ron Yang, J. Liou, K. Nepali, 2018, Journal of medicinal chemistry.

Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma

Chia-Ron Yang, C. Teng, J. Liou, 2015, Oncotarget.